Insecticides (india) Limited · NSE:INSECTICID

Insecticides (india) — Q2 FY2021 Earnings Presentation

25 slides from Insecticides (india)'s earnings presentation, Nov 9, 2020

  1. Slide 1: Q2 FY2021 Earnings Presentation

    (BSE: 532851 NSE: INSECTICID) Q2 FY2021 Earnings Presentation

  2. Slide 2: Q2 FY2021 Highlights

    Q2 FY2021 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 5,031 4,558 720 577 488 414 14.3% 12.7% 9.7% 9.0% Q2 FY20 Q2 FY21 Q2 FY20 Q2 FY21 Q2 FY20 Q2 FY21 EBITDA Margin (%) PAT Margin (%) Quarter Highlights: • Total branded sales declined by 15% due to uneven r

  3. Slide 3: H1 FY2021 Highlights

    H1 FY2021 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 8,617 8,654 1,354 1,070 847 655 9.8% 15.7% 12.4% 7.5% H1 FY20 H1 FY21 H1 FY20 H1 FY21 H1 FY20 H1 FY21 EBITDA Margin (%) PAT Margin (%) Half Year Highlights: • Total branded sales decline marginally by 2%.

  4. Slide 4: Products Freshness Index

    Products Freshness Index Proven track record of successful new product launches exhibits IIL’s strong R&D capabilities and continues to provide competitive edge 571 535 Gross Revenue from new product launches (Rs. Cr.) 30 478 70 90 420 66 89 59 131 92 319 299 148 90 15 11 9 26 13 9 221 33 45 38 10 4

  5. Slide 5: Management Commentary

    Management Commentary Commenting on the results, Mr. Rajesh Aggarwal, Managing Director, said: “Second quarter of the fiscal year had a varied experience for the agriculture and agrochemicals sector, the quarter was marked with normal monsoon on an average, resulting in adequate soil moisture and im

  6. Slide 6: Growth Strategy

    Growth Strategy R& D will results in New product Phase out Generic Products Exports launches in Maharatna Category • Focus on in-house R&D and international • Working on registration in new • Phasing out the Generic Products (high partners to launch new products countries with 100+ export agreements

  7. Slide 7: Capabilities and Geographical Presence

    Capabilities and Geographical Presence R&D Manufacturing • NABL QC Labs • 5 Formulations plant • In-house R&D Centre 01 02 • 2 Technical synthesis plants • JV with OAT Agrio Co. • 1 Biological manufacturing plant* Japan for dedicated R&D Centre Development Marketing & Training 04 03 • Sale & market

  8. Slide 8: Leading Maharatna Brands

    Leading Maharatna Brands PULSOR : Systemic fungicide with preventive and curative action; controls Rice Sheath Blight LETHAL : Organo-phosphorus group of insecticides; controls insects through contact, stomach and vapour action HERCULES Hercules is a broad-spectrum insecticide for control of sucking

  9. Slide 9: Research & Development

    Research & Development State-of-the-art in house R&D centre established in 2005, augmented by product innovation R&D center, formulation R&D centre and biological R&D centre • Approved by DSIR, Ministry of Science and Technology 12 Patents Received • Working on new formulations and new combination p

  10. Slide 10: Business Overview

    Business Overview Insecticides India - A Leading Agro Chemicals Manufacturing Company Engaged in the manufacturing and marketing of crop-protection products Rs. 865 Cr 60,000+ Four product categories: Insecticides, Herbicides, Fungicides, H1FY21 Sales Retail Outlets Biologicals and Plant Growth Regu

  11. Slide 11: Financial Performance

    Financial Performance Q2 Y-o-Y Q1 Q-o-Q Half Year Y-o-Y (Rs. Million) FY2021 FY2020 Growth(%) FY2021 Growth(%) FY2021 FY2020 Growth(%) Operating Revenue 4,558 5,031 (9.4)% 4,096 11.3% 8,654 8,617 0.4% Other Income 50 18 186.6% 11 349.1% 62 27 128.1% Total Revenue 4,609 5,049 (8.7)% 4,107 12.2% 8,716

  12. Slide 12: Leverage Profile

    Leverage Profile Successfully reduced debt by Rs. 1,280 million in last six months (Rs. Million) FY2017 FY2018 FY2019 FY2020 H1FY2021 Long Term Debt 283 145 68 19* 14 Company continues to strengthen Balance sheet through debt reduction and Short Term Debt 2,060 968 2,952 1,835 560 improving collecti

  13. Slide 13: Financial Trends - Quarterly

    Financial Trends - Quarterly Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 5,031 4,558 720 4,096 577 492 488 2,629 414 2,387 230 241 86 9.0% (25) 9.7% (73) 14.3% 3.3% 5.9% (1.0)% 12.0% 12.7% 8.7% (3.1)% Q2 FY20 Q3 FY20 Q4 FY20 Q1 FY21 Q2 FY21 Q2 FY20 Q3 FY20 Q4 FY20 Q1 F

  14. Slide 14: Financial Trends - Annual

    Financial Trends - Annual Strong Revenue and profitability growth in last 5 years Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 8.4% 14.1% 21.4% CAGR CAGR CAGR 13,632 11,935 1,872 1,224 10,733 1,559 9,882 9,942 1,478 840 860 1,114 15.7% 920 13.8% 597 10.2% 11.2% 11.4% 39

  15. Slide 15: Key Ratios

    Key Ratios Consistently high returns to shareholders and strong capital structure Dividend Payout Ratio Return on Equity 18.5% 16.5% 15.3% 4.82 12.9% 11.8% 9.8% 2.41 2.41 2.41 2.41 2.00 12.0% 5.9% 11.6% 8.3% 4.1% 6.3% FY16 FY17 FY18 FY19 FY20 H1FY21 FY16 FY17 FY18 FY19 FY20 H1 FY21 Payout Ratio Retu

  16. Slide 16: Working Capital Cycle

    Working Capital Cycle Management is fully committed to improving its working capital cycle (Working Capital Days) 313 263 209 190 195 188 189 184 151 158 135 115 116 124 115 98 93 89 86 76 78 80 75 73 Payables Receivables Inventory Net Working Capital FY2016 FY2017 FY2018 FY2019 FY2020 H1 FY21 • Net

  17. Slide 17: Cash Flow from Operations vs Free Cash Flows

    Cash Flow from Operations vs Free Cash Flows Generated strong cash flows to support growth plans and mitigate potential risk (Rs. Mn) 2,419 2,134 1,815 1,535 1,561 1,369 845 655 40 (99) (1,331) (1,706) FY2016 FY2017 FY2018 FY2019 FY2020 H1 FY21 Cash Flow from Operations Free Cash Flows 17

  18. Slide 18: Segment Reporting –H1FY2021

    Segment Reporting –H1FY2021 Net Sales by Product Category Net Sales by Segment 9% 2% 3% 24% Insecticides 33% B2C 56% Herbicides 73% B2B Fungicides Exports PGR Net Sales vs Internal Consumption Breakdown of Top Seller Range in B2C Sales 49% 51% 50% 50% Maharatna Internal Products Consumption Other Pr

  19. Slide 19: Segment Reporting –H1FY2021

    Segment Reporting –H1FY2021 Net Sales by Segment (Rs. Mn) Net Sales by Emphasized Product Category (Rs. Mn) -2.4% +7.4% +24.4% +7.3% -10.5% 6,500 6,344 3,540 3,175 3,169 2,960 1,895 2,034 222 276 B2C B2B Exports Maharatna Products Other Products H1FY20 H1FY21 H1FY20 H1FY21 • Higher contribution from

  20. Slide 20: Recent Announcements

    Recent Announcements Insecticides (India) launches Made in India Insecticide “Dominant” for Paddy and Cotton • Active Ingredient: Dinotefuran 20% SG • Product Category: Neonicotinoid group of Insecticides • Insecticides (India) will make its technical and formulation in India Key Features: • Effecti

  21. Slide 21: FY2021 Outlook

    FY2021 Outlook Opportunities India is currently the world’s fourth largest producer of Quarterly Outlook agrochemicals. Normal monsoon and improved kharif Increased demand for herbicides due to migrant labour issue performance should drive growth. India’s current in Punjab and Haryana. Recent locust

  22. Slide 22: Disclaimer

    Disclaimer This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Insecticides India Limited (“Insecticides India” or the Company) future b

  23. Slide 23: Insecticides (India) Ltd. contact details

    Insecticides (India) Ltd. (CIN: L65991DLl996PLC083909) 401-402, Lusa Tower Azadpur Commercial Complex Delhi - 110033 Telefax: +91 11 - 27679700 - 04 (5 Lines) info@insecticidesindia.com www.insecticidesindia.com

  24. Slide 24: Q2 FY2021 Results - Press Release

    Press Release Nov 09, 2020 Q2 FY2021 Results - Press Release Delhi, India, Nov 09, 2020: Insecticides India Limited (referred to as “IIL” the “Company”), one of the premier agrochemical companies in India, today announced its financial results for the second quarter ending September 30, 2020. Perfor

  25. Slide 25: Financials Results – Q2 FY2021

    Press Release Nov 09, 2020 Financials Results – Q2 FY2021 FY2021 *** About Insecticides India: Insecticides (India) Ltd. (IIL), is a BSE and NSE listed, India's leading and one of the fast growing Agrochemicals manufacturing company. IIL has emerged as a front-line performer in India's crop care mar

Insecticides (India) — Q2 FY2021 Earnings Presentation on 6ix